Singapore
Scaling medical aesthetic partnership model (85+ clinics in USA & Europe) across the region. We bring together a platform of clinic owners with shared equity and financial upside. Together, we accelerate growth with strategic capital, a global network of fellow leaders and centralized operations (finance, HR, IT, legal, procurement, marketing and more) that transform administrative burdens into competitive advantages. I believe that growth and personal growth solve all problems. Unlocking the full potential of our team and community naturally fuels the organizational momentum to attract and retain world-class talent. Previously, I was COO for Lucence (scaling longevity & Medicare-reimbursed cancer diagnostics), VC and Chief of Staff at Monk's Hill Ventures (Series A startup investments), Co-Founder of CozyKin (acquired), Bain management consultant and infantry sergeant. I am a UC Berkeley honors and Harvard MBA graduate, SID Accredited Director, Amazon bestselling author, and have been recognized by Forbes 30 Under 30 and Prestige 40 Under 40. I pay it forward to the Southeast Asia community by co-hosting BRAVE, the region's #1 tech podcast (global top 10%), where we provide educational insights for 80,000+ monthly listeners. All profits are reinvested into the community. I also invest in the next generation of founders (50+ investments) as a partner at Orvel Ventures and regional chapter head for Harvard Alumni Angels (elected Board Director of the HBS Club of Singapore). I previously founded Conjunct Consulting, an award-winning social enterprise that supported 100+ local health and community nonprofits. I taught startup growth & venture fund strategy as a commended adjunct lecturer at National University of Singapore and Singapore Management University. I am always open to invitations to publicly discuss the future of healthcare, leadership and entrepreneurship. I have served as a keynote speaker, panelist and moderator for global audiences across Harvard, SuperReturn Asia, SWITCH, e27 Echelon, Institute of Policy Studies and many others. Outside of work, I am a proud dad of my two daughters, a rucker who finds balance in nature, and a reader of longevity, self-help and science fiction.
After scaling to 85+ medical aesthetic clinics across North America and Europe, we’re officially bringing the CPP partnership to Asia. Clinic owners are often forced to choose between struggling with administrative burdens alone or surrendering their vision to private equity. CPP Asia offers a third way. We provide world-class operational support, procurement advantages and strategic capital, all while ensuring that physicians remain the heart of their business. Built by owners, for owners, we help you scale efficiently without losing your unique identity. Here’s what we believe in: 1. People-First Culture: We believe that by taking care of our teams and clinicians, they in turn provide remarkable care for our patients. We collaborate only with partners who embody respect, humility, and teamwork. 2. Physician-Led Innovation: Our network provides early access to proven treatments, advanced technology and shared clinical expertise across North America, Europe, and Asia. 3. Operational Excellence: We centralize the "heavy lifting" of HR, IT, marketing, and finance so you can focus on what matters most: your patients. We offer a long-term alternative to traditional exit strategies. Whether you are looking to maximize financial returns through collaborative upside or seeking a professional team to mitigate operational risk, CPP Asia provides the infrastructure for your practice to reach its full potential. Learn more: We’re looking for the region’s leading medical aesthetic operators and specialists to shape the future of aesthetics in Asia. If you know a physician leader in Singapore who fits this vision, please message me or forward this message to them. We’re always happy to discuss this more over coffee.
Network-driven VC investing ~$100K USD follower checks in seed & pre-A Southeast Asia startups. Fully deployed and currently in "harvest phase" governance and fiduciary oversight of existing portfolio
Notable investments include: 3cat (smartphone marketplace), Baskit (Indonesia B2B CPG value chain), Charter (space SaaS), Eazy (insurance digitalization SaaS), EDGE Tutor (B2B tutor outsourcing), Eratani (rice agritech), Esevel (Managed IT platform), Eze (B2B electronics wholesale), Fonos (Vietnam #1 audiobook platform), Fresh Factory (Indonesia cold chain), HD Mall (Thailand #1 D2C health marketplace), Innowave (semiconductor AI), Nodeflair (Tech career platform), Pollen (Asia's #1 B2B liquidation platform), Rently (landlord management), Rekosistem (Indonesia waste management), Ringkas (Indonesia's #1 home ownership platform), Solmatoss (furniture wholesale marketplace), Tiger New Energy (battery manufacturing & value chain), Zenith Education (O2O Tutoring), and others
Growth: Professionalized global P&L through strategic revenue growth, rigorous unit economics mapping and organizational efficiency. Negotiated and secured strategic collaborations with Mayo Clinic Laboratories, Agilus (India’s largest lab network) and key healthcare partners. Partnered with CEO on successful growth capital fundraising for USA scale-up and international expansion by leading financial modeling, pitch decks, legal reviews, due diligence and strategic deployment of proceeds. Professionalization: Institutionalized governance for management, Board and shareholders by rigorous financial reporting, signed financial audits, corporate budget approval and growth forecasting. Hired and digitized Finance, People and Marketing functions to establish a high-performance operational engine for global growth.
Pioneer precision oncology company transforming cancer care. With headquarters in Palo Alto and Singapore, we specialize in developing ultrasensitive and non-invasive liquid biopsy tests. These tests enable the detection and treatment of cancer with just a single draw of blood, providing critical, life-changing information for early detection and effective treatment strategies. Our state-of-the-art services are delivered worldwide through our CLIA-licensed and CAP-accredited laboratories. In 2022, Lucence secured Medicare approval, thus expanding the reach to millions of patients in the United States under the Medicare reimbursement scheme. Notable investors include IHH Healthcare (one of the world’s largest private healthcare networks), Heliconia Capital (Temasek subsidiary), SGInnovate and more.
Invested in founders who will transform millions of lives. Led investment and board observer for Ordinary Folk, Asia's top healthcare provider for stigmatized health conditions. Scouted and invested in Acme (streamlined banking APIs) and Key.ai (community management platform). Upgraded deals engine with data enrichment and action-learning feedback loops.
Upgraded deals engine with data enrichment and action-learning feedback loops. Built MHV fund strategy through executive offsites, department OKRs, and founder, portco & employee NPS. Designed venture scouts program for pre-seed and seed investments. Launched Angsana Council, Southeast Asia think tank. MHV is Southeast Asia's leading VC fund investing in Pre-A and A tech startups that will transform millions of lives.
Led the Guidepost at Home team to integrate the acquisition of the CozyKin platform. Launched decentralized at-home care nationally to support families impacted by school pandemic closures and retain jobs for teachers. Scaled operations to thousands of families across 56 schools in 28 states. Collaborated to successfully secure emergency authorization from childcare regulators in New York, California, Texas, Illinois, and Oregon.